46. Malignant rheumatoid arthritis Clinical trials / Disease details
Clinical trials : 4,325 / Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02350881 (ClinicalTrials.gov) | May 2013 | 19/1/2015 | Mid-term Outcomes of First MTP Arthroplasty With Primus™ FGT Implant. | A Post-Market Observational Study to Evaluate Safety and Performance of Primus™ FGT Implant at a Minimum of 5 Years Follow-up | Hallux Limitus of Left Great Toe;Rheumatoid Arthritis;Arthritis of 1st Metatarsophalangeal Joint;Osteoarthritis;Bunion;Hallux Limitus of Right Great Toe | Device: Primus FGTI (Flexible Great toe Implant) | Tornier, Inc. | NULL | Completed | 18 Years | N/A | All | 70 | N/A | Italy |